Naming drug trials is an artform.

October 18, 2026 0 Comments

Naming drug trials is an artform. Here’s the latest result from Lilly’s retatrutide. “In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over 80 weeks, with more than half no longer meeting the BMI criteria for obesity.” ~ learn more